BOTOX MARKET TO WITNESS HUGE GROWTH FROM 2020-2030 AND FOCUSING ON TOP KEY PLAYERS – ALLERGAN, IPSEN GROUP
Botox refers to Botulinum Toxins, a protein which is produced by Gram-positive, spore forming bacterium Clostridium Botulinum. Botulinum toxin is a potent neurotoxin protein that inhibits signal conduction to the neuromuscular endplate. The toxin acts directly on the neuromuscular endplate and other cholinergic synapses where it inhibits the release of neurotransmitter acetylcholine, leading to muscular paralysis of the affected fiber and loss of target organ function. Limited and diluted amounts of botulinum toxin is used for treating several therapeutic indications such as cervical dystonia, lazy eye, muscle contractures, hyperhidrosis, chronic migraine and bladder dysfunction among others. There are seven serologically distinct types of botulinum toxin such as A, B, C1, D, E, F, and G. Botulinum toxin types A and B are commonly used in medical preparations for treatment of muscle spasms.Major Key Players of the Botox Market are:
Allergan, Ipsen Group, Medytox, Merz Pharma, HUGEL, US WorldMeds, Galderma Laboratories, L.P., Revance Therapeutics, Inc, Eisai Co., Ltd. and DAEWOONG CO.LTD among others.
No comments:
Post a Comment